1. Home
  2. COGT vs SCVL Comparison

COGT vs SCVL Comparison

Compare COGT & SCVL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • COGT
  • SCVL
  • Stock Information
  • Founded
  • COGT 2014
  • SCVL 1978
  • Country
  • COGT United States
  • SCVL United States
  • Employees
  • COGT N/A
  • SCVL N/A
  • Industry
  • COGT Biotechnology: Pharmaceutical Preparations
  • SCVL Clothing/Shoe/Accessory Stores
  • Sector
  • COGT Health Care
  • SCVL Consumer Discretionary
  • Exchange
  • COGT Nasdaq
  • SCVL Nasdaq
  • Market Cap
  • COGT 984.0M
  • SCVL 976.9M
  • IPO Year
  • COGT 2018
  • SCVL 1993
  • Fundamental
  • Price
  • COGT $8.90
  • SCVL $35.44
  • Analyst Decision
  • COGT Buy
  • SCVL Buy
  • Analyst Count
  • COGT 6
  • SCVL 2
  • Target Price
  • COGT $14.67
  • SCVL $51.00
  • AVG Volume (30 Days)
  • COGT 1.3M
  • SCVL 311.2K
  • Earning Date
  • COGT 11-12-2024
  • SCVL 11-21-2024
  • Dividend Yield
  • COGT N/A
  • SCVL 1.53%
  • EPS Growth
  • COGT N/A
  • SCVL N/A
  • EPS
  • COGT N/A
  • SCVL 2.82
  • Revenue
  • COGT N/A
  • SCVL $1,233,144,000.00
  • Revenue This Year
  • COGT N/A
  • SCVL $7.75
  • Revenue Next Year
  • COGT N/A
  • SCVL $7.02
  • P/E Ratio
  • COGT N/A
  • SCVL $12.55
  • Revenue Growth
  • COGT N/A
  • SCVL 2.06
  • 52 Week Low
  • COGT $3.67
  • SCVL $22.30
  • 52 Week High
  • COGT $12.61
  • SCVL $46.92
  • Technical
  • Relative Strength Index (RSI)
  • COGT 28.97
  • SCVL 44.52
  • Support Level
  • COGT $9.97
  • SCVL $37.22
  • Resistance Level
  • COGT $11.16
  • SCVL $39.29
  • Average True Range (ATR)
  • COGT 0.78
  • SCVL 1.03
  • MACD
  • COGT -0.25
  • SCVL 0.32
  • Stochastic Oscillator
  • COGT 2.02
  • SCVL 52.37

About COGT Cogent Biosciences Inc.

Cogent Biosciences Inc a biotechnology company focused on developing precision therapies for genetically defined diseases. It designs rational precision therapies that treat the underlying cause of disease and improve the lives of patients. Its program CGT9486, is a selective tyrosine kinase inhibitor designed to potently inhibit the KIT D816V mutation as well as other mutations in KIT exon 17. In the vast majority of cases, KIT D816V is responsible for driving Systemic Mastocytosis (SM), a serious disease caused by the unchecked proliferation of mast cells. Exon 17 mutations are also found in patients with advanced gastrointestinal stromal tumors (GIST), a type of cancer with strong dependence on oncogenic KIT signaling.

About SCVL Shoe Carnival Inc.

Shoe Carnival Inc is a family footwear retailer that offers a broad assortment of dress, casual and athletic footwear for men, women, and children with an emphasis on national name brands such as Nike, Skechers, Adidas, Puma, HEYDUDE, Converse, Vans, and Crocs. They operate their business as one reportable segment based on the similar nature of products sold; merchandising, distribution, and marketing processes involved; target customers; and economic characteristics of our stores and e-commerce platforms. Its bricks-first, omnichannel approach provides customers easy access to a wide assortment of branded footwear for work, athletics, daily activities, and special events via a choice of delivery channel.

Share on Social Networks: